A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

Figures & data

Table 1. Rotavirus admissions in infants <12 months of age/100,000 population by year and by study site.

Site/Year	2008	2009	2010	2011	2012	2013*
Site 1	405.4	344.8	142.2	628.5	0.0	0.0
Site 2	183.7	419.2	139.2	139.4	140.0	116.1
Site 3	113.8	115.1	0.0	468.1	125.9	150.6

*January – May 2013 inclusive.

The universal rotavirus vaccine program in Sites 1 and 2 began in December 2010. Vaccine coverage in Site 1 in Study year one (2011) was 93.4% for one dose and 91.2% for 2 doses; and in year 2 (2012) it was 93.1% and 90.3% for dose one and 2 respectively. In Site 2, vaccine coverage in year one was 33.1% for dose one and 33.6% for 2 doses; and in year 2 it was 38.3% and 33% for dose one and 2 respectively.

Table 2. Rotavirus admission in children one year of age to < 2 y of age/100,000 population by year and study site.

Site/Year	2008	2009	2010	2011	2012	2013*
Site 1	790.2	675.7	69.0	1564.7	0.0	0.0
Site 2	312.1	321.5	46.6	69.6	69.7	55.7
Site 3	57.4	113.8	0.0	229.6	0.0	466.6

*January – May 2013 inclusive.

The universal rotavirus vaccine program in Sites 1 and 2 began in December 2010. Vaccine coverage in Site 1 in Study year one (2011) was 93.4% for one dose and 91.2% for 2 doses; and in year 2(2012) it was 93.1% and 90.3% for dose one and 2 respectively. In Site 2, vaccine coverage in year one was 33.1% for dose one and 33.6% for 2 doses; and in year 2 it was 38.3% and 33% for dose one and 2 respectively.

Figure 1. Rotavirus admissions in children < 12 months of age/1000 population/month January 2008—May 2013.